SATELIT-HF: Sleep Apnea Treatment During Cardiac Rehabilitation of Congestive Heart Failure Patients

Sponsor
French Cardiology Society (Other)
Overall Status
Completed
CT.gov ID
NCT01120548
Collaborator
ResMed (Industry), ResMed Foundation (Other), Adep Assistance (Other)
300
19
2
51
15.8
0.3

Study Details

Study Description

Brief Summary

Sleep disordered breathing (SDB) is a frequent comorbidity for heart failure patients. Its prevalence varies according to the seriousness of the condition of the patients, but it is present in approximately 50% of patients. Screening patients for SDB and managing them by providing adapted ventilation therapy should improve their quality of life or even their prognosis. Moreover, SDB lowers nocturnal cardiovascular recovery abilities and leads to an increase in fatigability and, as a result, exercise intolerance in patients with heart failure. Physical training as part of a cardiac rehabilitation programme provides many benefits, including improving patients' exercise capacities. Our hypothesis is that adapted sleep disordered breathing therapy during rehabilitation will lead to an improvement in rehabilitation results.

Condition or Disease Intervention/Treatment Phase
  • Other: ventilation therapy
N/A

Detailed Description

Controlled, randomised, multicentre study. Patients will be assessed prior to starting the rehabilitation programme with regard to exercise tolerance parameters (cardiopulmonary exercise test, 6 minute walk test), ultrasound parameters and biological parameters (Na, Hb, BNP).

The cardiac rehabilitation programme will include education, secondary prevention and physical training components in each of the two groups. The physical training component will include a minimal "base" of activities that is identical for both groups. The nocturnal therapy device will be adapted to the type of SDB specific to each patient (central, mixed, obstructive). The randomisation will be stratified by centre according to predictive factors for performance improvement during rehabilitation.

The main objective is to evaluate the improvement in physical performance resulting from adapted ventilation on SDB compared to physical training alone in patients with heart failure.

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
SLEEP DISORDERED BREATHING DURING CARDIAC REHABILITATION A Study of the Improvement in Physical Performance of Patients With Heart Failure During Cardiac Rehabilitation Due to the Correction of Sleep Disordered Breathing
Study Start Date :
Sep 1, 2010
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Rehabilitation + Ventilation Group

Patient Heart Failure with sleep disordered breathing who follows ventilation therapy and physical training.

Other: ventilation therapy
The service provider will provide the patient with the ventilation device and will explain to the patient how to operate the device and how to fit the mask according to the specifications. There will be an oximetry recording during ventilation on the first night. After the first night, the ventilation parameters recorded by the machine and the oximetry results will be read and used to adjust the settings. Starting the first week and at the end of the programme, the following ventilation parameters will be collected: compliance, leaks, AHI, ventilation mode, pressures used. The threshold of length of nocturnal ventilation fixed to 3h per night on average in order to consider a compliant patient.

No Intervention: Rehabilitation Only Group

Outcome Measures

Primary Outcome Measures

  1. Peak VO2 [Day 1]

    The primary endpoint is the relative improvement of exercise tolerance, estimated using the changes in the patient's peak VO2 measured before starting and after finishing the rehabilitation programme between the both group.

  2. Peak VO2 [Between 4 to 9 weeks]

    The primary endpoint is the relative improvement of exercise tolerance, estimated using the changes in the patient's peak VO2 measured before starting and after finishing the rehabilitation programme between the both group.

Secondary Outcome Measures

  1. Physical training compliance [between 4 and 9 weeks]

    Secondary endpoints include compliance with rehabilitation sessions, estimated by comparing the number of sessions in which training was effectively carried out with the anticipated number of sessions and other exercise tolerance parameters (maximum power, duration of exercise, submaximal parameters) in each group.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who have NYHA class II to IIIb heart failure, operated or not, ischemic or not, without significant valve pathology.

  • Referred to cardiac rehabilitation

  • With an EF < 40%

  • And an apnea-hypopnea index > 15/h (determined by a nasal flow recording method)

  • Have signed the consent document to participate in the study.

Exclusion Criteria:
  • Patients who have been stabilised for less than 10 days (inotropic drugs or modification of the anticipated resynchronisation or PM parameters)

  • Patients who already use sleep disordered breathing devices

  • Resting SBP < 80 mmHg (averaged over 3 separate measurements)

  • Recent angioplasty (within the last 10 days)

  • Infarction within the last 10 days

  • Heart surgery within the last 15 days

  • Valve dysfunction requiring surgery

  • Uncontrolled high blood pressure (BP > 180 and/or 110 mmHg)

  • Anaemia (Hb < 9g/dl)

  • Haemodialysis

  • Patient receiving circulatory assistance

  • Severe chronic respiratory failure (FEV1 < 1000) or hypercapnia greater than 46 mmHg

  • Patient incapable of performing a 6 minute walk test and an exercise test

  • Absolute contraindication for an exercise test and/or physical training according to the recommendations of the French Society of Cardiology

  • Evolving myopericarditis

  • Severe ventricular rhythm disorders that do not stabilise with treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Médical de Bligny Briis sous Forges France 91640
2 Clinique de Châtillon Châtillon France 92320
3 Hôpital Albert Chenevier Créteil France 94000
4 Dieulefit Santé Dieulefit France 26220
5 Hôpital Arthur Gardiner Dinard France 35800
6 Clinique de cardiopneumologie Durtol France 63830
7 Hôpital Sud - Institut de Rééducation Echirolles France 38130
8 Hôpital Corentin Celton Issy-les-moulineaux France 92133
9 Clinique de La Mitterie Lomme France 59160
10 Centre IRIS Marcy l'Etoile France 69280
11 Centre Cardio-Vasculaire Valmante Marseille France 13009
12 Clinique de réadaptation cardiaque Cardiocéan Puilboreau France 17138
13 Hôpital Nord 6 Saint Etienne France 42055
14 Hôpital Intercommunal Sud Léman Valserine Saint Julien en Genevois France 74164
15 Centre William Harvey - le Haut Boscq Saint Martin d'Aubigny France 50190
16 Centre de réadaptation cardiaque Leopold Bellan Tracy le Mont France 60170
17 Institut Régional de Réadaptation Vandoeuvre-les-Nancy France 54500
18 La Maison du Mineur Vence France 06140
19 Centre Hospitalier Calmette Yerres France 91330

Sponsors and Collaborators

  • French Cardiology Society
  • ResMed
  • ResMed Foundation
  • Adep Assistance

Investigators

  • Principal Investigator: Sonia Corone, MD, Centre Médical de Bligny
  • Principal Investigator: Marie-Christine Iliou, MD, Hôpital Corentin Celton

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
French Cardiology Society
ClinicalTrials.gov Identifier:
NCT01120548
Other Study ID Numbers:
  • 2008-07
First Posted:
May 11, 2010
Last Update Posted:
Mar 9, 2015
Last Verified:
Mar 1, 2015
Keywords provided by French Cardiology Society
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 9, 2015